Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

Journal of Hypertension

Volumn 19, Issue 10, 2001, Pages 1783-1787

  Kurland, Lisa ^a   Melhus, Håkan ^a   Karlsson, Julia ^a   Kahan, Thomas ^b   Malmqvist, Karin ^b   Öhman, K Peter ^c   Nyström, Fredrik ^c   Hägg, Anders ^a   Lind, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c University of Health Science   (Sweden)

Author keywords

Genes; Pharmacology; Renin angiotensin system; Treatment

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; IRBESARTAN;

ADULT; ALLELE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

EID: 0034816118     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200110000-00012     Document Type: Article

References (21)

1. Is insulin resistance a predictor of the blood pressure response to anti-hypertensive treatment?
2. Renin profiling for diagnosis and treatment of hypertension
3. Antihypertensive treatment according to age, plasma renin and race
4. Renin profiling for diagnosis, risk assessment, and treatment of hypertension
5. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: Investigation of renin-angiotensin system genes
6. Regression of left ventricular hypertrophy in human hypertension with irbesartan
7. Mistyping ACE heterozygotes
8. Linkage of the angiotensinogen gene to essential hypertension
9. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension
10. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
11. Beta blockade in hypertension: Past, present and future
12. 1166A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II
13. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A (1166)C polymorphism in essential hypertensives on a high sodium diet
14. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II
15. Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects
16. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men
17. The angiotensin I converting enzyme gene and predisposition to high blood pressure
18. ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans
19. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition
20. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
21. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context